← back to search

Rouven Hoefflin

University of Freiburg · DE
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Single-cell and spatial transcriptomics, Cancer Genomics and Diagnostics, Renal cell carcinoma treatment, and Cancer Immunotherapy and Biomarkers.
h-index
14
citations
1,514
works
32
NIH funding
primary concept
Biology
email

Recent publications

The Curated Cancer Cell Atlas provides a comprehensive characterization of tumors at single-cell resolution
Nature Cancer 2025cited by 24position: middledoi
Integrative spatial analysis reveals a multi-layered organization of glioblastoma
Cell 2024cited by 281position: middledoi
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment
Cancer Research 2024cited by 21position: middledoi
Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours
Nature 2023cited by 513position: middledoi
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response
British Journal of Haematology 2023cited by 18position: middledoi
ATR represents a therapeutic vulnerability in clear cell renal cell carcinoma
JCI Insight 2022cited by 17position: middledoi
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis
Cancers 2021cited by 54position: firstdoi
Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma
Cancers 2021cited by 14position: firstdoi
HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
Nature Communications 2020cited by 277position: firstdoi
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
Nature Communications 2016cited by 79position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2020–2022)Melanie Boerries · University of Freiburg3 papers (2020–2022)Mojca Adlesic · University of Fribourg3 papers (2020–2022)Ian J. Frew · Heidelberg University3 papers (2020–2022)Philipp Seidel · Carl Zeiss (Germany)3 papers (2020–2022)Bernd Lahrmann · University Hospital Heidelberg2 papers (2020–2021)Itay Tirosh · American Committee for the Weizmann Institute of Science2 papers (2024–2025) · 2 papers (2021–2022)Mathias Heikenwälder · German Cancer Research Center2 papers (2020–2021)Niels Grabe · Heidelberg University2 papers (2020–2021)Sabine Harlander · University of Regensburg2 papers (2020–2021)Christoph Schell · Rockefeller University2 papers (2020–2022)Danijela Heide · German Cancer Research Center2 papers (2020–2021)Patrick Metzger · University of Freiburg2 papers (2020–2022)Dana Hirsch · Weizmann Institute of Science1 papers (2024–2024)Fengshen Kuo · Rutgers, The State University of New Jersey1 papers (2020–2020)L. Nicolas Gonzalez Castro · Broad Institute1 papers (2024–2024) · 1 papers (2022–2022)Alissa Greenwald · Hebrew University of Jerusalem1 papers (2024–2024)Frank T. Zenke · Merck (Germany)1 papers (2022–2022)